European Archives - Page 678 of 1061 - European Medical Journal

Management of Hepatitis C in People Who Inject Drugs: Some Practical Lessons from the Frontline of the Elimination Battle

One of the critical populations in this battle to achieve elimination is people who inject drugs (PWID), who in the UK represent 85% of the hepatitis C…

EMJ Hepatology 7.1 2019

A warm welcome to all our readers to this year’s edition of EMJ Hepatology, a journal packed full of cutting-edge advancements and exciting new research.

Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate

Clinical studies of the TPO-R agonist lusutrombopag included a large proportion of high-risk bleeding patients and therapy with this agent has been shown…

Vaccine Structure Could Impact Cancer Immunotherapy Success

THE EFFICACY of immunotherapy vaccines can be impacted by the structure of the vaccine regardless of its composition, a team of researchers from…

The role of biomarker testing in treatment decision making: Current and future perspectives

Prof Ahmad Awada is Head of Oncology Medicine Department at the Jules Bordet Institute, Brussels, Belgium, and specialises in the…

Cancer Treatment Response Could be Predicted by Tumour Mutations

TUMOUR mutations could be used to predict patients’ responses to cancer treatment drugs, according to the results of a recent study…

Review of the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2019

Profs Dominique Valla and Tom Hemming Karlsen welcomed the approximately 9,000 delegates from 125 countries, with the former offering some sound advice…

The Role of Adipose Tissue in Metabolic and Cardiovascular Complications After Liver Transplantation

Metabolic and cardiovascular complications are an important burden in patients after liver transplantation (LT) for many reasons, including as a result…

ILC 2019 Interview: Professor Dina Tiniakos

We met with EMJ Hepatology Editorial Board member, Prof Dina Tiniakos, at the ILC, to discuss her career path and her experience at the congress…

Editor's Pick: Overview of Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease

This review aims to give an overview and update our knowledge of AATD associated with liver disease and discusses possible new therapeutic strategies…